Comparison of β-lactam regimens for the treatment of Gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics | Zendy

David S. Burgess | Zendy; Christopher R. Frei | Zendy

Open Access

Comparison of β-lactam regimens for the treatment of Gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics

Author(s) -

David S. Burgess,

Christopher R. Frei

Publication year - 2005

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dki335

Subject(s) - cefepime , ceftazidime , imipenem , piperacillin , medicine , acinetobacter baumannii , microbiology and biotechnology , piperacillin/tazobactam , doripenem , tazobactam , cephalosporin , pseudomonas aeruginosa , biology , antibiotics , antibiotic resistance , genetics , bacteria

This study utilized pharmacokinetics/pharmacodynamics to compare beta-lactam regimens for the empirical and definitive treatment of gram-negative pulmonary infections in the ICU.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research